Search by Drug Name or NDC

    NDC 61919-0875-71 MAPAP 325 mg/1 Details

    MAPAP 325 mg/1

    MAPAP is a ORAL TABLET in the HUMAN OTC DRUG category. It is labeled and distributed by DirectRX. The primary component is ACETAMINOPHEN.

    Product Information

    NDC 61919-0875
    Product ID 61919-875_87d6ce0b-19db-84e0-e053-2a95a90a0090
    Associated GPIs
    GCN Sequence Number n/a
    GCN Sequence Number Description n/a
    HIC3 n/a
    HIC3 Description n/a
    GCN n/a
    HICL Sequence Number n/a
    HICL Sequence Number Description n/a
    Brand/Generic n/a
    Proprietary Name MAPAP
    Proprietary Name Suffix n/a
    Non-Proprietary Name MAPAP
    Product Type HUMAN OTC DRUG
    Dosage Form TABLET
    Route ORAL
    Active Ingredient Strength 325
    Active Ingredient Units mg/1
    Substance Name ACETAMINOPHEN
    Labeler Name DirectRX
    Pharmaceutical Class n/a
    DEA Schedule n/a
    Marketing Category OTC MONOGRAPH NOT FINAL
    Application Number part343
    Listing Certified Through 2023-12-31

    Package

    NDC 61919-0875-71 (61919087571)

    NDC Package Code 61919-875-71
    Billing NDC 61919087571
    Package 100 TABLET in 1 BOTTLE (61919-875-71)
    Marketing Start Date 2019-05-01
    NDC Exclude Flag N
    Pricing Information N/A

    Standard Product Labeling (SPL)/Prescribing Information SPL 87d6ce0b-19da-84e0-e053-2a95a90a0090 Details

    Revised: 5/2019